Inventaire - your friends and communities are your best library

Toward the potential cure of leukemias in the next decade

author

Hagop Kantarjian

1952 -

Michael J. Keating

published in: Cancer

date of publication: 2018-10-06

language: English

Cites articles 147

Date

Title

Authors

2018-03-01

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.

Hagop Kantarjian, Elias Jabbour
2018-03-22

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

François Guilhot, Elisabetta Abruzzese, Hagop Kantarjian, Andreas Hochhaus, Michele Baccarani, Carlo Gambacorti-Passerini, Jorge Eduardo Cortes, Jane F Apperley, Daniel J DeAngelo, Moshe Talpaz, Stephanie Lustgarten, Frank G Haluska, Javier Pinilla-Ibarz, Charles Chuah, Ronald Paquette, Philipp le Coutre
2018-01-15

Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.

Hagop Kantarjian, Alessandra Ferrajoli, William G Wierda, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Joseph D. Khoury, Naveen Pemmaraju, Courtney D DiNardo, Nicholas J. Short, Koji Sasaki, Rebecca S Garris, Naval Daver, Jeffrey C. Jorgensen, Musa Yilmaz, Xuelin Huang, Steven M Kornblau, Jovitta Jacob, Jan A Burger
2018-01-22

Blinatumomab for minimal residual disease in adults with B-precursor acute lymphoblastic leukemia.

Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Helmut Diedrich, Monika Brüggemann, Jonathan E Benjamin, Ralf C Bargou
2018-02-01

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Adriana Balduzzi, Carl H. June, Bruce L. Levine, Stephan A Grupp, C Peters
2018-02-01

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
2018-02-02

Flai (fludarabine, cytarabine, idarubicin) plus low-dose gemtuzumab ozogamicin as induction therapy in cd33-positive aml: Final results and long term outcome of a phase ii multicenter clinical trial.

Cristina Papayannidis, Giovanni Martinelli, Michele Baccarani, Ilaria Iacobucci, Filippo Gherlinzoni, Renato Fani
2018-06-02

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML

Stéphane de Botton, Christophe Willekens
2018-01-12

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

Hagop Kantarjian, Marina Konopleva, Anthony Letai, Courtney D DiNardo, Keith W Pratz, Martha Arellano, Daniel A Pollyea, Jalaja Potluri, Brenda Chyla, Rod Humerickhouse, Mack Mabry, Brian A Jonas
2018-02-22

Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes

James P. Allison, Guillermo Garcia-Manero
2017-05-11

Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia

Hagop Kantarjian, Alessandra Ferrajoli, Jorge Eduardo Cortes, Gautam Borthakur, Tapan Kadia, Farhad Ravandi, Guillermo Garcia-Manero, Naveen Pemmaraju, Naval Daver, Brittany Knick Ragon, Maro Ohanian, Betul Oran
2017-02-20

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Tamas Masszi, María Teresa Gómez Casares, Giuseppe Saglio, Wiktor Jedrzejczak
2017-10-12

FCR achieves long-term durable remissions in patients with IGHV-mutated CLL.
2017-03-22

Acute lymphoblastic leukemia in adolescents and young adults.

Hagop Kantarjian
2017-10-02

Philadelphia chromosome-like acute lymphoblastic leukemia

Sarah K. Tasian, Stephen P Hunger, Mignon L Loh
2017-03-29

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Cristina Papayannidis, Adele K Fielding
2017-08-18

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia.

Nicholas J. Short, Hagop Kantarjian, William G Wierda, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Jorge Eduardo Cortes, Courtney D DiNardo, Naval Daver, Koichi Takahashi, Jan A Burger
2017-06-27

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
2017-03-01

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Miguel A Sanz, Hagop Kantarjian, Robin Foà, Hervé Dombret, Ewa Lech-Marańda, Adele K Fielding
2017-08-31

Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial

Hagop Kantarjian, Zeev Estrov, Jorge Eduardo Cortes, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Nicholas J. Short, Koji Sasaki, Rebecca S Garris, Maria R Khouri, Richard E Champlin, Partow Kebriaei, Xuelin Huang, Michael E Rytting, Jovitta Jacob, Koichi Takahashi
2017-07-14

A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.

Nicholas J. Short, Hagop Kantarjian, Zeev Estrov, William G Wierda, Gautam Borthakur, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Jorge Eduardo Cortes, William Plunkett, Naveen Pemmaraju, Tapan M Kadia, Courtney D DiNardo, Koji Sasaki, Naval Daver, Mark J Brandt, Xuelin Huang, Lianchun Xiao, Susan M O'Brien
2017-06-23

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

Guido Marcucci, Konstanze Döhner, Hartmut Döhner, Clara D. Bloomfield, Martin S. Tallman, Francesco Lo-Coco, Gerhard Ehninger, Frederick R. Appelbaum, Christian Thiede, Richard A. Larson, Dietger Niederwieser, Ben L Sanford, Sergio Amadori, Kristina M Laumann, Rebecca B Klisovic, Miguel A Sanz, Hubert Serve, Arnold Ganser, Jürgen Krauter, Susan Michelle Geyer, Joseph M Brandwein
2017-06-06

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Arthur E. Frankel, Hagop Kantarjian, Christophe Willekens, Stéphane de Botton, Ian W. Flinn, Paresh Vyas, Martin S. Tallman, Robert Douglas Knight
2017-12-04

Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.

Hagop Kantarjian, Farhad Ravandi, Naval Daver
2017-07-06

The emerging role of immune checkpoint based approaches in AML and MDS.

James P. Allison, Hagop Kantarjian, Guillermo Garcia-Manero, Naval Daver, Padmanee Sharma
2017-01-01

Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.

Hagop Kantarjian, Farhad Ravandi, Naval Daver, Lucia Masarova, Padmanee Sharma
2016-11-30

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Pier Luigi Zinzani, Anthony Ho, Alessandro Gozzetti, Francesco Forconi, Constantine S. Tam, Brunangelo Falini, Farhad Ravandi, Thorsten Zenz, Daniel Catovsky, Claire E. Dearden, Monica Else, Martin S. Tallman, Tadeusz Robak, Timothy G. Call, Clive S Zent, Emili Montserrat
2016-06-15

Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial

Preetesh Jain, Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Susan O'Brien, Farhad Ravandi, Sherry Pierce, Michael J. Keating, Jeffrey C. Jorgensen, Mark J Brandt, Rajyalakshmi Luthra, Dai Chihara, Rebecca Poku, Phillip S Thompson, Jan A Burger
2016-12-21

Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

Hagop Kantarjian, Alessandra Ferrajoli, Stefan Faderl, Zeev Estrov, Srdan Verstovsek, William G Wierda, Jorge Eduardo Cortes, Gautam Borthakur, Tapan Kadia, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Sherry Pierce, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Courtney D DiNardo, Naval Daver, Mark J Brandt, Rajyalakshmi Luthra, Steven M Kornblau, Yasmin Abaza, Elihu Estey, Deborah A McCue, Maria C Foudray, Keyur P Patel
2016-10-31

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

Francesco Albano, Massimo Breccia, Konstanze Döhner, Hartmut Döhner, Fabio Efficace, Mariadomenica Divona, Francesco Lo-Coco, Gerhard Ehninger, Uwe Platzbecker, Christian Thiede, Claudio Fozza, Christoph Röllig, Christian H Brandts, Mathias Hänel, Bernd Hertenstein, Arnold Ganser, Laura Cicconi, Helmut R Salih, Lorella Melillo, Mohammed Wattad, Giuseppe Avvisati, Francesca Paoloni, Marco Vignetti, Felicetto Ferrara, Paola Fazi, Marco Sborgia, Eros Di Bona, Roberto Cairoli, Giorgio La Nasa, Peter Brossart, Michael Lübbert, Chiara Frairia, Alfonso Maria D'Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Sergio Amadori, Franco Mandelli
2016-03-24

Moving treatment-free remission into mainstream clinical practice in CML.

David Ross
2016-05-14

Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen

Hagop Kantarjian, Alessandra Ferrajoli, Gautam Borthakur, Farhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, Jorge Eduardo Cortes, Naveen Pemmaraju, Tapan M Kadia, Marina Y Konopleva, Elias J Jabbour, Rebecca S Garris, Naval Daver, Jeffrey C. Jorgensen, Michael E Rytting, Steven M Kornblau, Anna Franklin, Susan M O'Brien

Article - wd:Q57020375

Welcome to Inventaire

the library of your friends and communities

learn more